ArticleCureus2022

Management of Attention Deficits and Behavioral Dyscontrol With an Evening-Dosed Methylphenidate Formulation in Smith-Magenis Syndrome.

Matthew R Narlesky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.